Management of infections in critically ill patients

Surgical Infections

Volumn 15, Issue 5, 2014, Pages 474-478

  Hranjec, Tjasa ^a   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; DROTRECOGIN; PROBIOTIC AGENT; PROCALCITONIN;

ANTIBIOTIC THERAPY; BATH; BODY TEMPERATURE; COOLING; CRITICALLY ILL PATIENT; EXTRACORPOREAL OXYGENATION; GASTROINTESTINAL TRACT; HEALTH CARE QUALITY; HUMAN; IMMUNE RESPONSE; INFECTION; MORBIDITY; MORTALITY; NUTRITION; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT MONITORING; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIAL INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; INTENSIVE CARE;

BACTERIAL INFECTIONS; CHLORHEXIDINE; CRITICAL ILLNESS; CROSS INFECTION; HUMANS; INTENSIVE CARE;

EID: 84912011228     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2013.154     Document Type: Review

References (25)

1. Snitkin ES, Zezasny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4:148ra116.
2. Köser CU, Holden MT, Ellington MJ, et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012;366:2267-2275.
3. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013;110:3507-3512.
4. Melsen WG, Rovers MM, Groenwold RH, et al. Attributable mortality of ventilator-associated pneumonia: A meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013;13:665-671.
5. Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: A multicentre, cluster-randomised, crossover trial. Lancet 2013;381:1099-1106.
6. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533-542.
7. Rosenthal VD, Rodrigues C, Alvarez-Moreno C, et al. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents: Findings of the International Nosocomial Infection Control Consortium. Crit Care Med 2012;40:3121-3128.
8. Sinuff T, Muscedere J, Cook DJ, et al. Implementation of clinical practice guidelines for ventilator-associated pneumonia: A multicenter prospective study. Crit Care Med 2013;41:15-23.
9. Petrof EO, Dhaliwal R, Manzanares W, et al. Probiotics in the critically ill: A systematic review of the randomized trial evidence. Crit Care Med 2012;40:3290-3302.
10. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013;368:1489-1497.
11. Reignier J, Mercier E, Le Gouge A, et al. Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: A randomized controlled trial. JAMA 2013;309:249-256.
12. Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: A randomized controlled clinical trial. Lancet 2013;381:385-393.
13. Lee GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 2012;367:1428-1437.
14. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: An individual patient data metaanalysis. Clin Infect Dis 2012;55:651-662.
15. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. Lancet Infect Dis 2013;13:426-435.
16. Hranjec T, Rosenberger LH, Swenson B, et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: A quasi-experimental, before and after observational cohort study. Lancet Infect Dis 2012;12:774-780.
17. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
18. Kalil AC, LaRosa SP. Effectiveness and safety of dro-trecogin alfa (activated) for severe sepsis: A meta-analysis and metaregression. Lancet Infect Dis 2012;12:678-686.
19. Annane D, Timsit JF, Megarbane B, et al. Recombinant human activated protein C for adults with septic shock. Am J Respir Crit Care Med 2013;187:1091-1097.
20. Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012;366:2055-2064.
21. Brechot N, Luyt CE, Schmidt M. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med 2013;41:1616-1626.
22. 1)-in-duced acute respiratory distress syndrome: A cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2013;187:276-285.
23. Schortgen F, Clabault K, Katsahian S, et al. Fever control using external cooling in septic shock: A randomized controlled trial. Am J Respir Crit Care Med 2012; 185:1088-1095.
24. Miller RR 3rd, Dong L, Nelson NC, et al. Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med 2013;188:77-82.
25. Levy MM, Artigas A, Phillips GS, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: A prospective cohort study. Lancet Infect Dis 2012;12:919-924.